NCT04341103 AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience Status UNKNOWN Phase N/A
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury Status UNKNOWN Phase PHASE3
NCT04340544 Hydroxychloroquine for the Treatment of Mild COVID-19 Disease Status TERMINATED Phase PHASE2
NCT04340414 Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP Status UNKNOWN Phase NA
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) Status COMPLETED Phase N/A
NCT04339816 Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial Status TERMINATED Phase PHASE3
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction Status COMPLETED Phase PHASE2
NCT04339660 Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia Status UNKNOWN Phase PHASE1/PHASE2
NCT04338958 Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation Status COMPLETED Phase PHASE2
NCT04338802 Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19 Status UNKNOWN Phase PHASE2
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 Status COMPLETED Phase NA
NCT04337541 Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System Status COMPLETED Phase NA